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Chem., 180, 647. THOMPSON, B. A. (1950) J. clin. Path., 3, 118. Chloromycetin in the Treatment of Typhus and Typhoid By R. LEWTHWAITE, D.M., F.R.C.P. Director of Colonial Medical Research (Lately Director, Institute for Medical Research, Kuala Lumpur, Malaya) I WISH to describe a piece of medical investigation carried out by a group of workers in a tropical country, Malaya. The project to undertake investigation in typhus and typhoid with chloromycetin was initiated by Dr. Joseph E. Smadel, Scientific Director of the Virus and Rickettsia Division of the United States Army Post-Graduate and Research School, Washington.
Scrub typhus is unknown in the United Kingdom, save for laboratory mishaps. It is a distinctive component member of that group of typhus diseases, one or the other of which occurs in each of the five continents. They may be briefly classified as louseborne, flea-borne, tick-borne and mite-borne, the last named of which is my first subject this evening. It is scrub typhus, identical with the classical tsutsugamushi disease of Japan. The former synonym supplanted the latter for obvious reasons when the disease flared up amongst the Allied Armies in the recent Japanese War in regions that are best indicated by an arc drawn from Northern Assam through Burma, Ceylon, Malaya, Indonesia, Indo-China, Queensland, New Guinea, Formosa, and Japan. In pre-war days it had not greatly obtruded in medical statistics. Only those who worked or sought recreation in jungle contracted it. During the war it emerged from comparative obscurity to menacing notoriety; 30,000 cases occurred in British, Australian and American forces, of whom some 100% died and 25 % were after lengthy convalescence invalided home. It is inoculated into man by one or other of a group of mites, Trombicula akamushi, Trombicula deliensis, &c.; the causal organism is the Rickettsia tsutsugamushi; the mite lives on the wild rat, and on some birds. Essentially a disease of mites and rats, the ebb and flow of jungle warfare necessitated man going into the haunts of this disease, and, in consequence, he frequently supplanted the rat as the host, and so contracted the disease.
During the war, much intensive investigation had been concentrated on it: Countermeasures are threefold, anti-rat, anti-mite, and anti-Rickettsial. Early in the war against the Japanese, investigations by Australian and American scientists, working independently, culminated in the demonstration that mite-poisons could be successfully used in the field by the impregnation of clothing, and that dibutyl phthalate or benzyl benzoate surpassed all others. According to the Australian Army Authorities, by this measure aloine, scrupulously applied, the incidence of the disease could be reduced by 75 %.
Anti-Rickettsial counter-measures made little headway during the war. Vaccines proved inconclusive. Recently, however, by another line of approach an astonishingly successful advance has been made in the development of the two antibiotics, chloromycetin and aureomycin. The usc of the former will receive precedence in this narrative, since the author has greater familiarity with it, and it was used almost exclusively in the Malayan work.
The drug originated from a mould, Streptomyces venezuela, isolated from a sample of soil taken in Venezuela and sent to Dr. Paul R. Burkholder, a botanist at Yale. He found it to have anti-bacterial activity, and therefore passed it to the Research Division of Messrs. Parke, Davis & Co., of Detroit, who found filtrates to be active. From these the active principle was isolated in pure crystalline form: on its being found in the laboratory to affect many viral and Rickettsial agents it was passed to Dr. Joseph E. Smadel, Director of the Virus and Rickettsia Division of the Research and Graduate School of the United States Army Department, for extended trials. Laboratory investigation soon revealed its curative value against the major Rickettsial infections when studied in laboratory mice and embryonated eggs. Since no significant signs of any toxicity due to the drug were observed, Dr. Smadel decided to proceed at once to human therapy.
The wartime in4oads of scrub typhus into casualty lists and into morale were fresh in the memory; new foci of incidence had revealed themselves in Malaya; civilian and soldier alike were frequently "at risk" when traversing secondary jungle. The Institute for Medical Research, Kuala Lumpur, had long been studying scrub typhus, and to it Dr. Smadel turned for laboratory space and collaborative effort in a projected evaluation of chloromycetin.
The protocols of the laboratory experiments in Washington were undoubtedly encouraging, especially in animals and chick embryos treated late in the infection, and I, the then Director of the Institute, had no hesitation in accepting Dr. Smadel's proposal to bring a hand-picked Scrub-Typhus Research Unit. A British Scrub Typhus Research Unit of three scientists, led by Dr. J. R. Audy, had already begun a field study of mites and vectors; and it seemed clear that progress must accrue.
Chloromycetin in the therapy of scrub typhus.-In Washington plans went rapidly ahead. During four months of preparation Dr. Smadel and two colleagues visited Mexico, and succeeded in obtaining 5 cases of epidemic (louse-borne) typhus, and 2 cases of murine (flea-borne) typhus. All responded promptly to chloromycetin therapy, including one elderly patient treated as late as the eighth day of the febrile reaction. The omens for the success of the drug in scrub typhus seemed thereby to be all the more favourable.
In March 1948 the American Scrub-Typhus Research Unit arrived in Singapore by a special army plane, in which were carried frigidaires, incubators, hot-air ovens and the like, together with two jeeps and the world supply of chloromycetin-I lb. in weight. Twenty-four hours after arrival at the up-country capital of Kuala Lumpur, the treatment of two soldiers, one British and one Malay, was begun by Dr. Theodore E. Woodward, the specialist physician of the Unit. Both soldiers were severely ill; in one, at least, the prognosis was doubtful, high fever of six or seven days' duration, a rash, a dermal lesion, lymphadenitis, severe headache and a marked toxicity constituting a very harassing infection.
The drug, chloromycetin, was given by mouth in the tablet form supplied by the makers; it was of the '"fermentation" type. The scheme of dosage was to give an initial "loading-dose" of 4 grammes (16 tablets) based on a ratio of 50 mg.'kg. body-weight. It was followed by decreasing doses every three hours as progress dictated. After the first twenty-four hours it was noted that the patients, though still febrile, showed no increase in toxicity. After forty-eight hours the temperature fell to normal, and remained so permanently. The drug was continued for six or seven days in the first few cases. Thereafter every case of scrub typhus received the drug; in all, the same dramatic defervescence and loss of toxicity were the outcome.
Favoured by an outbreak on a near-by rubber estate that yielded 40 cases, and by a trickle of cases incurred by the troops as a result of jungle training, a series of some 60 treated cases was rapidly amassed. Trial of different dosages made it clear that treatment for one day only was adequate-a loading dose of 4 grammes, followed by 025 gramme every three hours until a total of 6 grammes had been given. In later cases gelatin capsules of the drug swplanted the tablets.
We had thus witnessed an extraordinaiy event, namely, the immediate cure of a disease, long intractable to any specific therapy, achieved by the oral administration of a handful of tablets or capsules.
The next phase of the investigation was ushered in by the receipt from Washington of 11-25 grammes of a "new type of chloromycetin". Two patients (Gurkha soldiers) with a syndrome of considerable severity were readily secured. Both were treated for one day only, one receiving 5 5 grammes and one 4 grammes. In both, within forty-eight hours, the temperature fell to normal and toxicity vanished; uninterrupted convalescence ensued. The "new type" of the drug was chloromycetin prepared by synthesis in the Research Division of Messrs. Parke, Davis and Company, Detroit, by Rebstock and her colleagues (1949) . Raistrick (1949) has appraised this signal achievement, and his account should be consulted by those in quest of detail. Thereafter drug prepared by either method was used.
Another phase in the investigation of scrub typhus was the testing of chloromycetin as a prophylactic agent. No difficulty was experienced in obtaining adequate numbers of volunteers by advertisement in the daily newspapers. An infected field on a rubber estate near-by, with small areas adjacent to it, ensured that there would be no lack of mites if the climatic circumstances were favourable. Five highly organized field trials were carried through. Selected sites were chosen according to the tally of the vector mites on exposed white rats. Large consignments of white mice were flown to Kuala Lumpur from Melbourne, London and Manila for the detection of Rickettsihmia in the volunteers at various stages of the exposure to infection.
Two of the field exposures were outstanding in the data procured. In the first of them, 17 of 24 untreated controls contracted the infection after the usual incubation period of eleven to eighteen days; they were thereupon admitted to hospital and their infection terminated by chloromycetin. In the corresponding treated group of 22 cases, 1 gramme of the drug was given daily for the last nine days of exposure and the succeeding twelve days; all remained well until the thirty-first day, when a quiet confidence that Rickettsixe had been eliminated from each was rudely shattered by the onset of scrub typhus in 12 of the 22. The disease had been merely suppressed by the daily drug, on the cessation of which the usual incubation period began and ushered in the complete clinical syndrome of the disease.
The second field exposure, suitably modified in procedure, was more successful. Exposure was shortened to six days only; the two test groups received chloromycetin orally in once-weekly doses of 4 grammes for four and six weeks respectively, some starting on the sixth day and some on the tenth day from the beginning of exposure in the field. Of the 31 volunteers thus exposed, only one developed the disease sufficiently to warrant admission to hospital. Some of the others showed an incipient clinical syndrome (with Rickettsiemia) towards the end of the intervening weekly periods between doses; but it was effectively eliminated by the impending dosage of the drug, so that all of them remained ambulatory. None of the 30 developed the clinical disease after the completion of the prophylaxis.
Emanating from these experiments in human prophylaxis was an unexpected and (at the time) somewhat disconcerting finding. Patients who contract the disease in the course of their ordinary occupational duties seldom reach the hospital ward and receive a diagnosis before the fifth to sixth day of the clinical syndrome; in these, whether treated with chloromycetin or not, relapse does not occur. It was therefore puzzling to note that many of the volunteers who, since they were under daily observation, could be treated on the first to third day after onset, developed one or more relapses. They responded promptly to another course of the drug.
Mode of action of chloromycetin in scrub typhus.-Smadel (1950) has discussed at some length this aspect of the investigations. He concludes that chloromycetin is not rickettsiocidal but is rickettsiostatic; that the drug does not per se eliminate the organisms. In the naturally infected patient in whom treatment with the drug is perforce delayed until about the seventh day, the multiplication of the Rickettsi2v has stimulated the development of antibodies to a degree that, with the aid of the suppressive active of the drug, enables the bodily defences to control the infection permanently. In contrast, in the case of volunteers treated earlier in the infection, the bodily defences have lacked the stimulus of a comparable degree of multiplication of Rickettsie, and are inadequate, in spite of the administration of the drug, to control the infection effectively.
The treatment of typhoid fever.-In the differential diagnosis of scrub typhus, the physician has to consider leptospirosis, murine (flea-borne) typhus and typhoid fever. It was ine"vitable, therefore, that in the series of scrub typhus cases studied by the American Unit some that ultimately proved to be typhoid should be treated with chloromycetin. The eventuality was indeed welcomed, and the design of the investigation expanded accordingly. Reports giving interim results are now appearing in the literature, and should be consulted for detail (Woodward, Smadel et al., 1948 and , . It was soon evident that chloromycetin of the fermentation type, given orally as tablets, was effective therapeutically; for by the second or third day the toxicity was rapidly diminishing, and the temperature reached normal on the fourth day of treatment. These responses occurred whether treatment was begun early in the illness or late.
At the outset of the investigation Dr. Woodward, the physician of the Unit, gave an initial dose of 3 grammes, followed three-hourly by 0-5 or 0 25 gramme, with a gradual reduction of dosage on succeeding days. The first series received approximately 18 grammes spread over eight to nine days. Of these, a number relapsed after an average of eleven days from cessation of therapy; a further course of chloromycetin reproduced the mitigating features described above as resulting from the first treatment; second relapses occasionally occurred. It was clear that the treatment should be extended. As more of the drug became available, a small series of patients received the following dosage: an initial dose of 4 grammes, followed by 1-5 grammes at twelve-hour intervals during the four days of fever, then 1-5 grammes (single or divided) for the next seven days, followed by 1 gramme daily until the completion of fourteen to eighteen days of treatment. An alternative scheme designed to obviate relapses has been an initial period of treatment of five days (dosage as above), then five days without the drug, followed by a second period of treatment in dosage identical with the first. The synthetic type of drug was equally as effective as the fermentation type.
The chronic typhoid-carrier state has so far failed to respond to chloromycetin therapy; there is no reason to think that it has been increased, however. Smadel (1950) has reported that in concentrations of a few gamma per c.c. of culture media the drug will inhibit growth, but that even a thousand gamma will not kill the organisms. He would regard the balance between the host, the parasite and the immune mechanism as already established, and unlikely to be materially affected by a transient suppressive drug.
The Malayan series of typhoid cases was 44 in number; the only death was in a youth admitted to hospital in coma, and later found to be perforated. Since then inany similar series have added to the now very considerable tally of series which have been reported from various countries, most of them recording the same favourable results. There can be no doubt that, on present evidence, this drug, now made by synthesis, has greatly blunted the menace of typhoid fever.
